Researchers monitor Real-World safety of skin cancer drug in 323 patients
Knowledge-focused
Completed
This study looked at the long-term safety of the drug Odomzo (sonidegib) in 323 adults with a type of advanced skin cancer called locally advanced basal cell carcinoma (laBCC) that cannot be treated with surgery or radiation. Researchers collected real-world data on side effects,…
Sponsor: Sun Pharmaceutical Industries Limited • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC